News Focus
News Focus
Post# of 257473
Next 10
Followers 78
Posts 4417
Boards Moderated 0
Alias Born 01/17/2003

Re: DewDiligence post# 244777

Friday, 12/16/2022 9:36:53 PM

Friday, December 16, 2022 9:36:53 PM

Post# of 257473
For 131I-omburtamab, Serious Adverse Events (“SAE”) was found in 40.6% of the patients and were mostly related to myelosuppression.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today